Be The Match BioTherapies to Host Cell & Gene Therapy Standardization Summit
MINNEAPOLIS, Minn., May 30, 2018 – Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cellular therapies, announced that it will host a Cell & Gene Therapy Standardization Summit today from 8:00 a.m. to 2:00 p.m. CT in Minneapolis, Minn.
The event will bring together a small group of influential stakeholders in the cell and gene therapy industry to discuss the need for standardization and coordination amongst cell and gene therapy companies, the apheresis and transplant center networks, and other industry and professional groups involved in the development and delivery of therapies. Key topics for discussion include creating a system of standardization for apheresis and transplant centers, how to produce a quality and consistent starting material for new therapies and the development of an advocacy plan for industry-wide standardization.
About Be The Match BioTherapies
Be The Match BioTherapies partners with organizations pursuing life-saving cellular therapies in every stage of development—from discovery through commercialization. Built on the foundation established over the last 30 years by the National Marrow Donor Program®/Be The Match®, the organization has unparalleled experience managing cellular therapies. Its cell therapy supply chain delivery for autologous or allogeneic therapies is enabled by high-touch, personalized case management and MatchSource®, a robust, customizable software platform. By leveraging its deep experience in cell sourcing and collection, Be The Match BioTherapies provides cells consented for research, clinical or commercial use as well as clinical trials services through its research program, the CIBMTR. In addition, Be The Match BioTherapies has the infrastructure in place to collect patient outcomes at the time points required by regulatory authorities.